Chief Medical Officer

Executive Assistant To Chief Executive Officer

Mineralys announces new subgroup analyses from Phase 3 Launch-HTN trial

Mineralys Therapeutics Raises $287.5 Million in Upsized Notes Offering

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need

StockWatch: Ionis Scores on Phase III Data for Olezarsen

Director, Consumer & Patient Marketing

Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines for diseases driven by elevated aldosterone. The Director, Consumer and Patient Marketing will define and implement brand strategies to enhance brand awareness and patient experience, playing a key role in the launch of their product candidate through innovative marketing initiatives.

Sign up with Google

Sign in with Google